Document is current
Any future updates will be listed below
-
Authors
Haller, Paul M. https://orcid.org/0000-0002-7714-4446
Kellner, Caroline
Sörensen, Nils A.
Lehmacher, Jonas
Toprak, Betül
Schock, Alina
Hartikainen, Tau S.
Twerenbold, Raphael
Zeller, Tanja
Westermann, Dirk
Neumann, Johannes T.
-
Clinical Trials BETA
Clinical trials referenced in this document:
nct02355457 at ClinicalTrials.govDocuments that mention this clinical trial
Performance of the ESC 0/1-h and 0/3-h Algorithm for the Rapid Identification of Myocardial Infarction Without ST-Elevation in Patients With Diabetes (Results)
https://doi.org/10.2337/dc19-1327
Long-term outcome of patients presenting with myocardial injury or myocardial infarction
https://doi.org/10.1007/s00392-023-02334-w
Diagnostic performance of a device for acoustic heart sound analysis in patients with suspected myocardial infarction
https://doi.org/10.1136/openhrt-2022-002090
Predictive value of soluble urokinase-type plasminogen activator receptor for mortality in patients with suspected myocardial infarction
https://doi.org/10.1007/s00392-019-01475-1
Personalized diagnosis in suspected myocardial infarction
https://doi.org/10.1007/s00392-023-02206-3
-
Funding
Funding for this research was provided by:
German Center of Cardiovascular Research
Abbott Diagnostics
Universitätsklinikum Hamburg-Eppendorf (UKE)
- License Information
-
More Information
Article History
Received: 22 June 2023
Accepted: 24 October 2023
First Online: 20 November 2023
Declarations
:
: P.M.H. received travel grants from the German Center of Cardiovascular Research (DZHK) and is supported by a grant of the Faculty of Medicine, University of Hamburg and by a grant of the German Foundation for Heart Research; J.T.N. is recipient of a fellowship by the Deutsche Forschungsgemeinschaft (NE 2165/1-1) and reports speaker honoraria/consulting honoraria from PHC, Roche and Siemens; S.B. has received honoraria from Abbott Diagnostics, Siemens, Thermo Fisher, and Roche Diagnostics and is a consultant for Thermo Fisher; D.W. reports personal fees from Bayer, Boehringer-Ingelheim, Berlin Chemie, Astra Zeneca, Biotronik and Novartis. R.T. reports research support from the Swiss National Science Foundation (Grant No P300PB_167803), the Swiss Heart Foundation, the Swiss Society of Cardiology, the Cardiovascular Research Foundation Basel, and speaker honoraria/consulting honoraria from Abbott, Amgen, Astra Zeneca, Roche, Siemens, Singulex and Thermo Fisher. T.Z. was supported by the German Centre for Cardiovascular Research (FKZ 81Z1710101 and FKZ 81Z0710102). JTN, RT, and TZ are listed as co-inventors of an international patent on the use of a computing device to estimate the probability of myocardial infarction (International Publication Number WO2022043229A1) as well as co-founders and shareholders of the ART-EMIS Hamburg GmbH. All other authors report no conflict of interest.
